KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Return on Invested Capital: 2017-2022

  • Arbutus Biopharma's Return on Invested Capital was N/A to -0.20% in Q1 2022 from the same period last year, while for Mar 2022 it was -0.20%, marking a year-over-year change of. This contributed to the annual value of -0.97% for FY2019, which is 54.00% down from last year.
  • Latest data reveals that Arbutus Biopharma reported Return on Invested Capital of -0.20% as of Q1 2022, which was up 66.12% from -0.59% recorded in Q3 2019.
  • In the past 5 years, Arbutus Biopharma's Return on Invested Capital registered a high of -0.20% during Q1 2022, and its lowest value of -0.59% during Q3 2019.
  • For the 1-year period, Arbutus Biopharma's Return on Invested Capital averaged around -0.20%, with its median value being -0.20% (2022).
  • Data for Arbutus Biopharma's Return on Invested Capital shows a maximum YoY crashed of 33bps (in 2019) over the last 5 years.
  • Arbutus Biopharma's Return on Invested Capital (Quarterly) stood at -0.26% in 2018, then crashed by 33bps to -0.59% in 2019, then reached -0.20% in 2022.
  • Its last three reported values are -0.20% in Q1 2022, -0.59% for Q3 2019, and -0.26% during Q3 2018.